Krishna et al.; "9-0-Acetylation of Sialomucins: A Novel Marker of Murine CD4 T Cells That Is Regulated During Maturation and Activation", J. Exp. Med., 185:11 (1997). |
Agrawal et al.; "Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2", Nature Medicine 43-49 (1998). |
Agrawal et al., "Expression of MUC1 Mucin on Activated Human T Cells: Implications for a Role of MUC1 in Normal Immune Regulation" Cancer Research 4079-4081 (1998). |
Agrawal et al.; "The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy" Molecular Medicine Today 379-403 (1998). |
Agrawal et al., Nature Med. 4:43 (1998). |
Ligtenberg et al., Cancer Res. 52: 2318 (1992). |
Wesseling et al., J. Cell Biol. 129:255 (1995). |
Wesseling et al., Mol. Biol. Cell 7:565 (1996). |
Pemberton et al., "Antibodies to the cytoplasmic domain of the MUC1 mucin show conservation throughout mammals" Biochem. Biophys. Res. Comm. (USA) 185:167 (1992). |
Fontenot et al., "Biophysical Characterization of One-, Two-, and Three-Tandem Repeats of Human Mucin (muc-1) Protein Core" Cancer Research 53:5386 (1993). |